Background Next-generation sequencing of cancer predisposition genes is routinely used in hereditary cancer diagnostics.
Breast cancer risk after ovarian cancer in germline BRCA1/2 heterozygotes remains uncertain, with a recent large multicentre international study reporting lower-than-expected incidence in the first ...